Skip to content

Oncological and functional outcomes in the therapy of T1 / T2 glottic laryngeal carcinomas

Oncological and functional outcomes in the therapy of T1 / T2 glottic laryngeal carcinomas - /

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00026052
Enrollment
40
Registered
2021-08-13
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C32

Interventions

Group 1: transoral partial laryngectomy Group 2: transcervical partial laryngectomy Group 3: primary irradiated laryngeal carcinoma

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Female and male patients ? 18 years of age. - Initial diagnosis of histologically confirmed glottic laryngeal carcinoma of the Stages T1a/b or T2 - Curative intention to treat - Informed and written consent

Exclusion criteria

Exclusion criteria: - Age <18 years - Non-existent or limited legal capacity - Past head and neck cancer with surgical and / or conservative Treatment - Pre-existing limitations / limitations independent of the tumor in speech and swallowing function

Design outcomes

Primary

MeasureTime frame
Overall and recurrence-free survival compared between group 1 (transoral partial laryngectomy) and group 2 (transcervical partial laryngectomy) and group 3 (primary irradiated laryngeal carcinoma) after a follow-up of two years.

Secondary

MeasureTime frame
Pre- and posttherapeutic quality of life (assessed by standardized, validated questionnaires), postoperative voice and swallowing function (assessed by standardized, validated questionnaires as well as established and regularly used examinations), peri- and postoperative complications.

Countries

Germany

Contacts

Public ContactTobias Schulz

UNIVERSITÄTSKLINIKUM FREIBURG Klinik für Hals-Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie

tobias.schulz@uniklinik-freiburg.de

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026